← Eichor
Condition: Migraine With Aura Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Migraine With Aura

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
Phase 3 · 6 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05484349Trial Designs for Evaluating Migraine Treatment
NA · 2 location(s) · University of Aarhus · NCT06617832Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Phase 4 · 35 location(s) · Mayo Clinic · NCT06972056Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of
Phase 2 · 5 location(s) · Centre Hospitalier Universitaire de Nice · NCT04063540Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Atte
Phase 4 · 1 location(s) · Ain Shams University · NCT07022496BE WELL With Migraine: Brain Education and WELLness With Migraine
NA · 3 location(s) · Wake Forest University Health Sciences · NCT05987592Migraine Attack Pain Phase Prediction Study
Phase N/A · 1 location(s) · Fundación de Investigación Biomédica - Hospital Universitari · NCT06459635Neurogenetic And Hemodynamic Of Migraine Aura And Pfo
Phase N/A · 1 location(s) · Azienda Usl di Bologna · NCT07349004Gepant treAtments: EffectIveNess and tolERability (GAINER)
Phase N/A · 2 location(s) · University of Florence · NCT05903027New Methods for Evaluating Preventive Migraine Treatment
NA · 2 location(s) · University of Aarhus · NCT07071506Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06674772Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · 125 location(s) · Pfizer · NCT04743141Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide
NA · 1 location(s) · Danish Headache Center · NCT07021859A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
NA · 2 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06203873Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · 246 location(s) · Pfizer · NCT04649242RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Phase N/A · 2 location(s) · University of Florence · NCT06409832A Comprehensive Digital Care Program for Migraine Management
NA · 1 location(s) · Hinge Health, Inc · NCT07642414Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD
NA · 1 location(s) · Karolinska Institutet · NCT07348783Responding With Evidence and Access for Childhood Headaches
NA · 15 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05889624Study of EVO756 in Adults With Migraine
Phase 2 · 14 location(s) · Evommune, Inc. · NCT07616128Mind Body Balance for Pediatric Migraine
NA · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04715685Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · 129 location(s) · AbbVie · NCT05125302
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.